Forma Therapeutics Holdings Receivables

Forma Therapeutics Holdings (FMTX) currently reports a receivables of $15M as of June 2022. That compares with $15M in the prior-year period — up 0.9% year over year. Use the charts on this page to explore Forma Therapeutics Holdings's receivables history and peer comparisons.

Forma Therapeutics Holdings's receivables increased from $15M to $15M — a 0.9% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forma Therapeutics Holdings reported $15M in receivables as of June 2022. That compares with $15M in the prior-year period — up 0.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Forma Therapeutics Holdings, and consider following FMTX for alerts when major investors trade the stock.

Forma Therapeutics Holdings is classified in the Healthcare sector. On receivables, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FMTX with unrelated industries.